PIKFYVE and neoplasm: Further, we showed that Pikfyve knockout or inhibition with the phase 1-cleared inhibitor ESK981 substantially decreased tumor development and growth in murine and human in vivo models, suggesting that PIKfyve is essential for PDAC development and growth.